InSightec clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08
What changed in the last 30 days
5 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 1 with a minor change only.
- Notable: FREEDOM · Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease Start date pushed from Sep 2026 to Nov 2026
- Notable: MR-guided Focused Ultrasound Plus GCase Primary completion moved earlier from Dec 31, 2027 to Nov 1, 2026
- Minor: ExAblate Transcranial MRgFUS for Unilateral Pallidotomy · Parkinson's Disease Trial completed
- Notable: Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound Results posted: Oct 19, 2026
- Notable: LIMITLESS · Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets Primary completion pushed from Jun 1, 2027 to Jun 1, 2031
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 2 | |
| Phase 3 | 1 |
Not charted: 18 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Parkinson's Disease (9) · Dementia (2) · Alzheimer's Disease (1) · Glioma (1) · Huntington's Disease (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Prostate Cancer (1)
Get alerts when InSightec's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.